US2001034319A1PendingUtilityA1
Photothermal vascular targeting with bioreductive agents
Priority: Mar 23, 1999Filed: Jun 4, 2001Published: Oct 25, 2001
Est. expiryMar 23, 2019(expired)· nominal 20-yr term from priority
A61B 18/203A61N 5/062A61N 2005/0645A61B 2018/00458A61B 2018/00452
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of selectively enhancing the effect of photothermal vascular targeting on tumor regression by administration of a bioreductive agent is disclosed.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating a tumor characterized by nutrient-providing blood vessels comprising
irradiating the tumor or nutrient providing blood vessels in the presence of a bioreductive agent, providing an environment of hypoxia for the bioreductive agent, and allowing the bioreductive agent to act as a cytotoxic agent in a manner to reduce tumor size.Join the waitlist — get patent alerts
Track US2001034319A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.